Cargando…
Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer
BACKGROUND: Breast cancer is one of the leading cause of cancer-related deaths in women worldwide and increasing rapidly in developing countries. In the present study, we investigated the potential role and association of HSP70-2 with breast cancer. METHODS: HSP70-2 expression was examined in 154 tu...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034467/ https://www.ncbi.nlm.nih.gov/pubmed/27658496 http://dx.doi.org/10.1186/s13046-016-0425-9 |
_version_ | 1782455274818240512 |
---|---|
author | Jagadish, Nirmala Agarwal, Sumit Gupta, Namita Fatima, Rukhsar Devi, Sonika Kumar, Vikash Suri, Vaishali Kumar, Rajive Suri, Vitusha Sadasukhi, Trilok Chand Gupta, Anju Ansari, Abdul S. Lohiya, Nirmal Kumar Suri, Anil |
author_facet | Jagadish, Nirmala Agarwal, Sumit Gupta, Namita Fatima, Rukhsar Devi, Sonika Kumar, Vikash Suri, Vaishali Kumar, Rajive Suri, Vitusha Sadasukhi, Trilok Chand Gupta, Anju Ansari, Abdul S. Lohiya, Nirmal Kumar Suri, Anil |
author_sort | Jagadish, Nirmala |
collection | PubMed |
description | BACKGROUND: Breast cancer is one of the leading cause of cancer-related deaths in women worldwide and increasing rapidly in developing countries. In the present study, we investigated the potential role and association of HSP70-2 with breast cancer. METHODS: HSP70-2 expression was examined in 154 tumor and 103 adjacent non-cancerous tissue (ANCT) specimens and breast cancer cell lines (MCF7, BT-474, SK-BR-3 and MDA-MB-231) by RT-PCR, quantitative-PCR, immunohistochemistry, Western blotting, flow cytometry and indirect immunofluorescence. Plasmid driven short hairpin RNA approach was employed to validate the role of HSP70-2 in cellular proliferation, senescence, migration, invasion and tumor growth. Further, we studied the effect of HSP70-2 protein ablation on signaling cascades involved in apoptosis, cell cycle and Epithelial-Mesenchymal-Transition both in culture as well as in-vivo human breast xenograft mouse model. RESULTS: HSP70-2 expression was detected in majority of breast cancer patients (83 %) irrespective of various histotypes, stages and grades. HSP70-2 expression was also observed in all breast cancer cells (BT-474, MCF7, MDA-MB-231 and SK-BR-3) used in this study. Depletion of HSP70-2 in MDA-MB-231 and MCF7 cells resulted in a significant reduction in cellular growth, motility, onset of apoptosis, senescence, cell cycle arrest as well as reduction of tumor growth in the xenograft model. At molecular level, down-regulation of HSP70-2 resulted in reduced expression of cyclins, cyclin dependent kinases, anti-apoptotic molecules and mesenchymal markers and enhanced expression of CDK inhibitors, caspases, pro-apoptotic molecules and epithelial markers. CONCLUSIONS: HSP70-2 is over expressed in breast cancer patients and was involved in malignant properties of breast cancer. This suggests HSP70-2 may be potential candidate molecule for development of better breast cancer treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0425-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5034467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50344672016-09-29 Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer Jagadish, Nirmala Agarwal, Sumit Gupta, Namita Fatima, Rukhsar Devi, Sonika Kumar, Vikash Suri, Vaishali Kumar, Rajive Suri, Vitusha Sadasukhi, Trilok Chand Gupta, Anju Ansari, Abdul S. Lohiya, Nirmal Kumar Suri, Anil J Exp Clin Cancer Res Research BACKGROUND: Breast cancer is one of the leading cause of cancer-related deaths in women worldwide and increasing rapidly in developing countries. In the present study, we investigated the potential role and association of HSP70-2 with breast cancer. METHODS: HSP70-2 expression was examined in 154 tumor and 103 adjacent non-cancerous tissue (ANCT) specimens and breast cancer cell lines (MCF7, BT-474, SK-BR-3 and MDA-MB-231) by RT-PCR, quantitative-PCR, immunohistochemistry, Western blotting, flow cytometry and indirect immunofluorescence. Plasmid driven short hairpin RNA approach was employed to validate the role of HSP70-2 in cellular proliferation, senescence, migration, invasion and tumor growth. Further, we studied the effect of HSP70-2 protein ablation on signaling cascades involved in apoptosis, cell cycle and Epithelial-Mesenchymal-Transition both in culture as well as in-vivo human breast xenograft mouse model. RESULTS: HSP70-2 expression was detected in majority of breast cancer patients (83 %) irrespective of various histotypes, stages and grades. HSP70-2 expression was also observed in all breast cancer cells (BT-474, MCF7, MDA-MB-231 and SK-BR-3) used in this study. Depletion of HSP70-2 in MDA-MB-231 and MCF7 cells resulted in a significant reduction in cellular growth, motility, onset of apoptosis, senescence, cell cycle arrest as well as reduction of tumor growth in the xenograft model. At molecular level, down-regulation of HSP70-2 resulted in reduced expression of cyclins, cyclin dependent kinases, anti-apoptotic molecules and mesenchymal markers and enhanced expression of CDK inhibitors, caspases, pro-apoptotic molecules and epithelial markers. CONCLUSIONS: HSP70-2 is over expressed in breast cancer patients and was involved in malignant properties of breast cancer. This suggests HSP70-2 may be potential candidate molecule for development of better breast cancer treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0425-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-22 /pmc/articles/PMC5034467/ /pubmed/27658496 http://dx.doi.org/10.1186/s13046-016-0425-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Jagadish, Nirmala Agarwal, Sumit Gupta, Namita Fatima, Rukhsar Devi, Sonika Kumar, Vikash Suri, Vaishali Kumar, Rajive Suri, Vitusha Sadasukhi, Trilok Chand Gupta, Anju Ansari, Abdul S. Lohiya, Nirmal Kumar Suri, Anil Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer |
title | Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer |
title_full | Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer |
title_fullStr | Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer |
title_full_unstemmed | Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer |
title_short | Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer |
title_sort | heat shock protein 70-2 (hsp70-2) overexpression in breast cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034467/ https://www.ncbi.nlm.nih.gov/pubmed/27658496 http://dx.doi.org/10.1186/s13046-016-0425-9 |
work_keys_str_mv | AT jagadishnirmala heatshockprotein702hsp702overexpressioninbreastcancer AT agarwalsumit heatshockprotein702hsp702overexpressioninbreastcancer AT guptanamita heatshockprotein702hsp702overexpressioninbreastcancer AT fatimarukhsar heatshockprotein702hsp702overexpressioninbreastcancer AT devisonika heatshockprotein702hsp702overexpressioninbreastcancer AT kumarvikash heatshockprotein702hsp702overexpressioninbreastcancer AT surivaishali heatshockprotein702hsp702overexpressioninbreastcancer AT kumarrajive heatshockprotein702hsp702overexpressioninbreastcancer AT surivitusha heatshockprotein702hsp702overexpressioninbreastcancer AT sadasukhitrilokchand heatshockprotein702hsp702overexpressioninbreastcancer AT guptaanju heatshockprotein702hsp702overexpressioninbreastcancer AT ansariabduls heatshockprotein702hsp702overexpressioninbreastcancer AT lohiyanirmalkumar heatshockprotein702hsp702overexpressioninbreastcancer AT surianil heatshockprotein702hsp702overexpressioninbreastcancer |